COSMO Pharmaceuticals N.V. (C43) Q2 2026 Earnings Report
DE:C43 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.28
- Consensus EPS
- EUR 0.00
- Beat/Miss
- Missed by -EUR 0.28
- One Year Ago EPS
- -EUR 0.13
DE:C43 Q2 2026 Revenue Results
- Actual Revenue
- EUR 49.00M
- Expected Revenue
- EUR 25.57M
- Beat/Miss
- Beat by +EUR 23.42M
- YoY Revenue Growth
- -5.32%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/23/2026
- Time
- Before Open
- Conference Call
- Thursday, July 23, 2026
DE:C43 Upcoming Earnings
COSMO Pharmaceuticals N.V.'s next earnings date is estimated for March 24, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C43 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 24, 2027 | 2026 (Q4) | ―- | -0.1 | ― | ― |
| Jul 23, 2026 | 2026 (Q2) | 0.00-0.28 | -0.13 | -121.43% (-0.15) | |
| Mar 09, 2026 | 2025 (Q4) | 0.20-0.10 | 3.37 | -102.96% (-3.47) | |
| Jul 23, 2025 | 2025 (Q2) | ―-0.13 | 4.71 | -102.68% (-4.84) | |
| Mar 06, 2025 | 2024 (Q4) | 3.863.59 | -0.01 | 33840.00% (+3.60) | |
| Jul 24, 2024 | 2024 (Q2) | 0.584.71 | 0.09 | 5019.57% (+4.62) | |
| Mar 20, 2024 | 2023 (Q4) | 0.40-0.01 | 0.56 | -101.79% (-0.57) | |
| Jul 26, 2023 | 2023 (Q2) | ―0.09 | 0.48 | -80.67% (-0.38) | |
| Mar 23, 2023 | 2022 (Q4) | ―0.60 | 1.91 | -68.89% (-1.32) | |
| Jul 28, 2022 | 2022 (Q2) | ―0.48 | -0.4 | 219.30% (+0.88) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
